Search

1. Nadofaragene firadenovec and oportuzumab monatox for BCG-unresponsive, non-muscle invasive bladder cancer: effectiveness and value : final report

Author(s):

Atlas, Steven J., author
Touchette, Daniel R., author
Beinfeld, Molly, author
McKenna, Avery, author
Joshi, Mrinmayee, author
Chapman, Rick M., author
Pearson, Steven D., author
Rind, David M., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, January 15, 2021

Subject(s):

Antibodies, Monoclonal -- therapeutic use
Urinary Bladder Neoplasms -- drug therapy
Genetic Vectors -- therapeutic use
United States

2. JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and value : final evidence report

Author(s):

Atlas, Steven J., author
Fox, Grace E., author
Agboola, Foluso, author
Campbell, Jonathan D., author
Pearson, Steven D., author
Rind, David M., author
Brouwer, Elizabeth, author
Carlson, Josh, author
Chen, Yilin, (Of University of Washington), author
Hansen, Ryan N., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, February 27, 2023

Subject(s):

Antibodies, Monoclonal -- therapeutic use
Dermatitis, Atopic
Janus Kinase Inhibitors -- therapeutic use
United States

3. Medications for obesity management: effectiveness and value : final evidence report

Author(s):

Atlas, Steven J., author
Beinfeld, Molly, author
Lancaster, Victoria, author
Nhan, Emily, author
Moradi, Ashton, author
Rind, David M., author
Pearson, Steven D., author
Beaudoin, Francesca L., author
Kim, Kibum, author
Lien, Pei-Wen, author
Shah, Kanya, author
Touchette, Daniel R., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, October 20, 2022

Subject(s):

Bupropion
Glucagon-Like Peptide-1 Receptor Agonists
Liraglutide
Obesity -- drug therapy
Obesity Management -- methods
Phentermine
United States